Hepatic glucose uptake, gluconeogenesis and the regulation of glycogen synthesis

Diabetes/Metabolism Research and Reviews

Volumn 17, Issue 4, 2001, Pages 250-272

  Radziuk, J ^a   Pye, S ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Glucokinase; Lactate; Metabolic zonation; Metformin; Phosphorylase; Synthase

Indexed keywords

BIGUANIDE DERIVATIVE; GLUCOKINASE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLUCOSE 6 PHOSPHATE; GLYCEROL; GLYCOGEN; GLYCOGEN PHOSPHORYLASE; GLYCOGEN SYNTHASE; INSULIN; LACTIC ACID; METFORMIN; PYRUVIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONTROLLED STUDY; CORRELATION FUNCTION; DOG; ENZYME ACTIVATION; FOOD INTAKE; GLUCONEOGENESIS; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; GLYCOGEN LIVER LEVEL; GLYCOGEN SYNTHESIS; GLYCOLYSIS; HORMONE ACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; INHIBITION KINETICS; INSULIN RELEASE; LIVER CELL; METABOLITE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PORTAL VEIN; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; STOMACH ABSORPTION; STOMACH EMPTYING;

ANIMALS; DIABETES MELLITUS, TYPE 2; FOOD; GLUCOKINASE; GLUCONEOGENESIS; GLUCOSE; GLUCOSE INTOLERANCE; GLUCOSE-6-PHOSPHATASE; GLYCOGEN; HOMEOSTASIS; HUMANS; LIVER;

EID: 0034839569     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.217     Document Type: Review

References (244)

1. Muscle amino acid metabolism and gluconeogenesis
2. The position of fixed carbon in glucose from rat liver glycogen
3. A study of the chemical origin of glycogen by use of C14-labeled carbon dioxide, acetate and pyruvate
4. Source of carbon in hepatic glycogen synthesis during absorption of an oral glucose load in humans
5. Glycogen synthesis in the perfused liver of the starved rat
6. Glycogen synthesis in hepatocytes of the starved rat
7. Measurement of glucose recycling and liver glycogen synthesis in mice using labeled substrates
8. Restoration of glycogenesis in starved rats
9. Glucose load diverts hepatic glucogenic product from glucose to glycogen in vivo
10. Sources of hepatic glycogen formation in conscious rats during intraduodenal glucose loading
11. Glycogen synthesis in rat hepatocytes
12. Direction of carbon flux in starvation and after refeeding: In vitro and in vivo effects of 3-mercaptopicolinate
13. Efficient hepatic glycogen synthesis in refeeding rats requires continued carbon flow through the gluconeogenic pathway
14. Uber die Energieumwandlungen in Muskel. II. Das Schicksal der erholungsperiode des Muskels
15. Glycogen synthesis from lactate in three types of skeletal muscle
16. Lactate disappearance and glycogen synthesis in human muscle after maximal exercise
17. Muscle glyconeogenesis during recovery from exercise
18. Muscle glyconeogenesis during recovery from a prolonged swim in rats
19. The relationship between gluconeogenic substrate supply and glucose production in humans
20. In vivo evidence for hepatic autoregulation during FFA-stimulated gluconeogenesis in normal humans
21. Assessment methods of carbohydrate metabolism in the liver (glycogenolysis, gluconeogenesis, and glycogen synthesis)
22. Hormone-fuel inter-relationships during fasting
23. Insulin regulation of renal glucose metabolism in conscious dogs
24. Uptake and release of glucose by the human kidney: Postabsorptive rates and responses to epinephrine
25. Contributions by kidney and liver to glucose production in the postabsorptive state and after 60 h of fasting
26. Influence of endogenous insulin secretion on splanchnic glucose and amino acid metabolism in man
27. Basic studies on metabolic steady states: Incompletely mixed systems
28. Labeled glucose infusate technique in clamp studies. Is precise matching of glucose specific activity important?
29. Effects of lactate on pathways of glycogen formation in the perfused rat liver
30. The metabolic clearance of glucose: Measurement and meaning
31. Estimating rapid changes in the rates of glucose production from glycogenolysis and recycling through lactate
32. A noninvasive assessment of hepatic glycogen kinetics and post-absorptive gluconeogenesis in man
33. Liver glycogen in man - The effect of total starvation or a carbohydrate-poor diet followed by carbohydrate refeeding
34. Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR
35. Glycogen turnover during refeeding in the postabsorptive dog: Implication for the estimation of glycogen formation using tracer methods
36. Glycoconjugates as noninvasive probes of intrahepatic metabolism: Pathways of glucose entry into compartmentalized hepatic UDP-glucose pools during glycogen accumulation
37. Isotopic studies of carbohydrate metabolism in non-insulin-dependent diabetes mellitus
38. 2O for estimating rates of gluconeogenesis. Application to the fasting state
39. Applications of mass isotopomer analysis to nutrition research
40. The triumvirate: Beta-call, muscle and liver: A collusion responsible for NIDDM
41. Measurement of plasma glucose, free fatty acid, lactate, and insulin in patients with NIDDM
42. Effect of differences in glucose tolerance on insulin's ability to regulate carbohydrate and free fatty acid metabolism on obese individuals
43. Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects
44. Defective blood glucose counterregulation in diabetes is a selective form of autonomic neuropathy
45. Abnormal oral glucose tolerance and glucose malabsorption after vagotomy and pyloroplasty. A tracer method for measuring glucose absorption rates
46. Acarbose: A review of the US clinical experience
47. The effects of an alpha-glucoside hydrolase inhibitor on glycemia and the absorption of sucrose in man determined using a tracer method
48. The glucagon-like peptide-1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans
49. Subcutaneous injection of glucagon-like insulinotropic peptide reduces postprandial glycemia in non-insulin-dependent diabetes
50. Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide
51. The effect of systemic venous drainage of the pancreas on insulin sensitivity
52. Insulin sensitivity and glucose tolerance following transposition of pancreatic venous drainage to the systemic circulation
53. Systemic venous drainage of pancreas allografts as independent cause of hyperinsulinemia in type I diabetic recipients
54. Pathogenesis of NIDDM: A balanced overview
55. Tracer methods and the metabolic disposal of a carbohydrate load in man,
56. Skeletal muscle glycolysis, oxidation and storage of an oral glucose load
57. Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus
58. Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans
59. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin
60. Role of insulin in the hepatic handling of glucose
61. Influences of glucose loading and of injected insulin on hepatic glucose output
62. Insulin action in non-insulin-dependent diabetes mellitus: The relationship between hepatic and extrahepatic insulin resistance and obesity
63. Inhibition of hepatic glucose production by insulin in vivo in rats: Contribution of glycolysis
64. Lecons sur les phenomenes de la vie commune aux animaux et aux vegetaux
65. Physiological significance of the secretion of endogenous insulin into the portal circulation. IV. Hepatic uptake of glucose during glucose infusion in non-diabetic dogs
66. Physiological significance of the secretion of endogenous insulin into the portal circulation. V. The quantitative importance of the liver in the disposition of glucose loads
67. Absorption and disposition of a glucose load in the conscious dog
68. Hepatic and extrahepatic splanchnic glucose metabolism in the postabsorptive and glucose fed dog
69. Influence of oral glucose ingestion on splanchnic glucose and gluconeogenic substrate metabolism in man
70. Influence of maturity-onset diabetes on splanchnic glucose balance after oral glucose ingestion
71. Influence of hyperinsulinemia, hyperglycemia and the route of glucose administration on splanchnic glucose exchange
72. Oral glucose tolerance test: Effect of different glucose loads on splanchnic carbohydrate and substrate metabolism in healthy man
73. Forearm metabolism in obesity and its response to intraarterial insulin, characterization of insulin resistance and evidence for adaptive hyperinsulinism
74. Peripheral glucose metabolism in control subjects and diabetic patients during glucose, glucose-insulin and insulin sensitivity tests
75. Postprandial substrate deposition in human forearm and adipose tissues in vivo
76. Forearm glucose uptake during the oral glucose tolerance test in normal subjects
77. Quantitative relations between the oral and intravenous glucose tolerance curves
78. Plasma insulin response to oral and intravenous glucose: Studies in normal and diabetic subjects
79. The analysis of glucose measurements by computer simulation
80. Glucose uptake and production during the oral glucose tolerance test
81. Initial splanchnic extraction of ingested glucose in normal man
82. Experimental validation of measurements of glucose turnover in nonsteady state
83. Hepatic glycogen formation by direct uptake of glucose following oral glucose loading in man
84. Abnormal meal carbohydrate disposition in insulin-dependent diabetes
85. Postprandial hyperglycemia in patients with non-insulin-dependent diabetes mellitus
86. Simultaneous time-varying systemic appearance of oral and hepatic glucose in adults monitored with stable isotopes
87. Analysis of glucose production and disappearance rates following an oral glucose load in normal subjects: A double tracer approach
88. The disposal of an oral glucose load in healthy subjects
89. Skeletal muscle glycolysis, oxidation and storage of an oral glucose load
90. Contribution of abnormal muscle and liver glucose metabolism to post-prandial hyperglycemia in NIDDM
91. The role of fractional glucose extraction in the regulation of splanchnic glucose metabolism in normal and diabetic man
92. Differential effects of oral, peripheral, intravenous and intraportal glucose on hepatic glucose uptake and insulin and glucagon extraction in conscious dogs
93. Importance of the route of intravenous glucose delivery to hepatic glucose balance in the conscious dog
94. A portal-arterial glucose concentration gradient as a signal for an insulin-dependent net glucose uptake in perfused liver
95. Magnitude of negative arterial-portal glucose gradient alters net hepatic glucose balance in conscious dogs
96. Effect of hepatic nerves on disposition of an intraduodenal glucose load
97. Sensing by intrahepatic muscarinic nerves of a portal-arterial glucose gradient as a signal for insulin-dependent glucose uptake in the perfused rate liver
98. Induction of insulin resistance caused by hepatic cholinergic interruption and reversed by acetylcholine administration
99. A negative arterial-portal venous glucose gradient decreases skeletal muscle glucose uptake
100. Both positive and negative portal venous and hepatic arterial glucose gradients stimulate hepatic glucose uptake after the same amount of glucose is infused into the splanchnic bed in conscious dogs
101. The role of the liver in the disposal of orally administered 14C-glucose in the normal rat
102. Liver and muscle glycogen in man after glucose and fructose infusion
103. Direct assessment of liver glycogen storage by 13C-nuclear magnetic resonance spectroscopy and regulation of glucose homeostasis after a mixed meal in normal subjects
104. Hepatic glycogen in humans. II. Gluconeogenetic formation after oral and intravenous glucose
105. Glucokinase as glucose sensor and metabolic signal generator in pancreatic beta-cells and hepatocytes
106. Liver glucose-transporter. A basolateral protein in hepatocytes and intestine and kidney cells
107. Close linkage of glucose kinase locus on chromosome 7p to early-onset noninsulin dependent diabetes mellitus
108. Characterization of glucokinase mutations associated with maturity-onset diabetes of the young type 2 (MODY-2). Different glucokinase defects lead to a common phenotype
109. New perspectives on pancreatic islet cell glucokinase
110. Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations
111. Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects
112. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic and pancreatic β cell-specific gene knock outs using Cre recombines
113. The regulatory protein of liver glucokinase
114. Short-term control of glucokinase activity: Role of a regulatory protein
115. Competitive inhibition of liver glucokinase by its regulatory protein
116. Glucokinase regulatory protein may interact with glucokinase in the hepatocyte nucleus
117. Evidence for a role of glucose-induced translocation of glucokinase in the control of glycogen synthesis
118. Metabolic regulation of gene transcription in mammals
119. Stimulation of glucose-6-phosphatase gene expression by glucose and fructose-2,6-bisphosphate
120. Differential metabolic effects of adenovirus-mediated glucokinase and hexokinase I over-expression in rat primary hepatocytes
121. Glucose 6-phosphate produced by glucokinase, but not hexokinase, promotes the activation of hepatic glycogen synthase
122. Evidence from transgenic mice that glucokinase is rate-limiting for glucose utilization in the liver
123. Effect of glucose on uptake of radiolabeled glucose, 2-DG, 3-O-MG by the perfused rat liver
124. Transcriptional induction of glucokinase gene by insulin in cultured liver cells and its repression by the glucagon-cAMP system
125. Metabolic impact of glucokinase overexpression in liver. Lowering of blood glucose in fed rats is accompanied by hyperlipidemia
126. New knowledge regarding glucose-6-phosphatase gene and protein and their roles in the regulation of glucose metabolism
127. Glucose-6-phosphatase structure, regulation and function: An update
128. A re-evaluation of GLUT7
129. Evidence for changes in the conformational status of rat liver microsomal glucose-6-phosphate: Phosphohydrolase during detergent-dependent membrane modification
130. Evidence for a membrane exchangeable glucose pool in the functioning of rat liver glucose-6-phosphatase
131. Glycogen storage diseases
132. Genetic basis of glycogen storage disease type 1a: Prevalent mutations at the glucose-6-phosphatase locus
133. Evidence for suppression of hepatic glucose-6-phosphatase activity with carbohydrate feeding
134. Liver glucose-6-phosphatase activity is inhibited by refeeding in rats
135. The role of glucose-6-phosphatase in the action of insulin on hepatic glucose production in the rat
136. Glucose-6-phosphatase overexpression lowers glucose-6-phosphate and inhibits glycogen synthesis and glycolysis in hepatocytes without affecting glucokinase translocation
137. Unsaturated fatty acids associated with glycogen may inhibit glucose-6-phosphatase
138. Metabolic intermediates as potential regulators of glucose-6-phosphatase
139. Regulation of rat liver glucose-6-phosphatase gene expression in different nutritional and hormonal states: Gene structure and 5′-flanking sequence
140. Carbon flux via the pentose phosphate pathway regulates the hepatic expression of the glucose-6-phosphatase and phosphoenolpyruvate genes in conscious rats
141. Intracerebroventricular leptin regulates hepatic but not peripheral glucose fluxes
142. Glucose regulates in vivo glucose-6-phosphatase expression in the liver of diabetic rats
143. The discovery of glycogenin and the priming mechanism for glycogen biogenesis
144. Specific features of glycogen metabolism in the liver
145. Glycogen-2, a novel self-glucosylating protein involved in liver glycogen biosynthesis
146. Glucose induces the translocation of glycogen synthase to the cell cortex in rat hepatocytes
147. The liver and carbohydrate metabolism
148. The stimulation of glycogen synthesis and of glycogen synthetase in the liver by the administration of glucose
149. The sequential inactivation of glycogen phosphorylase and activation of glycogen synthetase after the administration of glucose to mice and rats. The mechanism of the hepatic threshold to glucose
150. The control of glycogen metabolism in the liver
151. Liver glycogen metabolism: An overview
152. Regulation of glycogen synthesis in the liver
153. Oral glucose effect on glycogen synthetase and phosphorylase in heart, muscle and liver
154. Metabolic effects of oral glucose in the liver of fasted rats
155. The inactivation of glycogen phosphorylase in rat is not a prerequisite for the activation of liver glycogen synthase
156. Stimulation of liver glycogen particle synthase D phosphatase activity by caffeine, AMP and glucose-6-phosphate
157. Glucose has to be phosphorylated to activate glycogen synthase, but not to inactivate glycogen phosphorylase in hepatocytes
158. Simultaneous synthesis and degradation of rat liver glycogen
159. 13C NMR studies of glycogen turnover in the perfused rat liver
160. Translocation and aggregation of hepatic glycogen synthase during the fasted to refed transition in rats
161. Demonstration of glycogen/glucose-1-phosphate cycle in hepatocytes from fasted rats. Selective deactivation of phosphorylase by 2-deoxy-2-fluoro-alpha-D-glucopyranosyl fluoride
162. Insulin, not glucose, controls hepatocellular glycogen deposition
163. Insulin regulates liver glycogen synthase and glycogen phosphorylase activity reciprocally in rhesus monkeys
164. In vivo regulation of liver and skeletal muscle glycogen synthase activity by glucose and insulin
165. Inhibition of hepatic glucose production by insulin in vivo in rats: Contribution of glycolysis
166. Insulin and glucose suppress hepatic glycogenolysis by distinct enzymatic mechanisms
167. Mechanisms by which glucose and insulin inhibit net hepatic glycogenolysis in humans
168. Loss of hepatic glycogen-binding subunit (GL) of protein phosphatase 1 underlies deficient glycogen synthesis in insulin-dependent diabetic rats and in adrenalectomized starved rats
169. Inhibition of phosphorylase-a by fructose-1-phosphate, α-glycerophosphate and fructose-1,6-diphosphate: Explanation for fructose-induced hypoglycemia in hereditary fructose intolerance and fructose-1,6-diphosphatase deficiency
170. Fructose effect to suppress hepatic glycogen degradation
171. Overexpression of protein targeting to glycogen (PTG) in rat hepatocytes causes profound activation of glycogen synthesis independent of normal hormone- and substrate-mediated regulatory mechanisms
172. Blood glucose homeostasis in rats with a deficiency of liver phosphorylase kinase
173. Inhibition of glycogenolysis enhances gluconeogenic precursor uptake by the liver of conscious dogs
174. Liver glycogen synthase deficiency: A rarely diagnosed entity
175. Identification of a mutation in liver glycogen phosphorylase in glycogen storage disease type VI
176. Variability of biochemical and clinical phenotype in X-linked liver glycogenesis with mutations in the phosphorylase kinase PHKA2 gene
177. Hepatic glycogen in humans. I. Direct formation after oral and intravenous glucose or after a 24-hr fast
178. 14 atoms from labelled substrate in vivo: A preliminary report
179. Glucose diverts hepatic gluconeogenic product from glucose to glycogen in vivo
180. Studies on the mechanism by which exogenous glucose is converted to liver glycogen in the rat
181. Quantitative estimation of the pathways followed in the conversion to glycogen of glucose administered to the fasted rat
182. Pathway of glycogen synthesis from glucose in hepatocytes maintained in primary culture
183. Active hepatic glycogen synthesis from gluconeogenic precursors despite high levels of fructose-2,6-bisphosphate
184. Role of the direct and indirect pathways for glycogen synthesis in rat liver in the postprandial state
185. Quantitation of the pathways of hepatic glycogen formation on ingesting a glucose load
186. Determination of pathways of glycogen synthesis and the dilution of the three carbon pool with [U-13C]glucose
187. Mechanism of liver glycogen repletion in vivo by nuclear magnetic resonance spectroscopy
188. Determination of the glycogen synthesis pathway by 13C nuclear magnetic resonance spectroscopy
189. Pathways of hepatic glycogen formation in humans following the ingestion of a glucose load in the fed state
190. Quantitation of hepatic glucose fluxes and pathways of hepatic glycogen synthesis in conscious mice
191. Predominant role of gluconeogenesis in the hepatic glycogen repletion of diabetic rats
192. The effects of ingested and intravenous glucose on forearm uptake of glucose and glucogenic substrate in normal man
193. The utilization of glucose and production of lactate by in vivo preparations of rat small intestine: Effects of vascular perfusion
194. Metabolic effects of oral glucose in the liver of fasted rats
195. In vitro study on the contribution of the rat intestine-pancreas to glucose homeostasis
196. Regional differences in adipocyte lactate production from glucose
197. Gut exchange of glucose and lactate in basal state and after oral glucose in postoperative patients
198. Glucose and glycogen metabolism following glucose ingestion: A turnover approach
199. Sources of carbon for hepatic glycogen synthesis in the conscious dog
200. The contribution of pyruvate cycling to loss of [6-3H]glucose during conversion of glucose to glycogen in hepatocytes: Effects of insulin, glucose and acinar origin of hepatocytes
201. Glycogen synthesis in amphibian oocytes: Evidence for an indirect pathway
202. Lactate release from isolated adipocytes: Influence of cell size, glucose concentration, insulin and epinephrine
203. Evidence for lactate production by human adipose tissue in vivo
204. Subcutaneous adipose tissue: A source of lactate production after glucose ingestion in humans
205. The role of skin in carbohydrate metabolism
206. Energy metabolism and the skin
207. Erythrocyte metabolism. II. Glucose metabolism and pathways
208. Rate of appearance and disappearance of plasma lactate after oral glucose: Implications for indirect-pathway hepatic glycogen repletion
209. Substrates and the regulation of hepatic glycogen metabolism
210. The coordinated regulation of hepatic glycogen formation in the perfused rat liver by glucose and lactate
211. Mechanism of metformin action in obese and lean NIDDM subjects
212. Metabolic effects of metformin in NIDDM
213. Effects of metformin on lactate uptake and gluconeogenesis in the perfused rat liver
214. Lactate and pyruvate stimulate the conversion of glucose to glycogen in hepatocytes by a mechanism that does not involve gluconeogenic flux
215. Inhibition of glucose-6-phosphate phosphohydrolase by 3-mercaptopicolinic acid and two analogs is metabolically directive
216. Effects of 3-mercaptopicolinic acid and a derivative of chlorogenic acid (S-3483) on hepatic and islet glucose-6-phosphatase activity
217. The role of cell swelling in the stimulation of glycogen synthesis by insulin
218. Mechanism of activation of liver glycogen synthase by swelling
219. Glutamine and the liver cell: Properties and concept of metabolic regulation by cell swelling
220. Hepatocyte heterogeneity in the metabolism of carbohydrates
221. Role of oxygen in the zonation of carbohydrate metabolism and gene expression in the liver
222. Autoregulatory switch from glycolysis to gluconeogenesis in rat hepatocyte suspensions. The problem of metabolic zonation of liver parenchyma
223. Glycogen synthesis from pyruvate in the periportal and from glucose in the perivenous zone in perfused liver from fasted rats
224. Measurement of metabolic fluxes through pyruvate kinase, phosphoenol pyruvate carboxykinase, pyruvate dehydrogenase, and pyruvate carboxylase in hepatocytes of different acinar origin
225. 2 of the glucagon-dependent activation of phosphoenolpyruvate carboxykinase gene and the insulin-dependent activation of the glucokinase gene in rat hepatocytes
226. Glyconeogenesis from L-proline involves metabolite inhibition of the glucose-6-phosphatase system
227. Role of liver in pathophysiology of NIDDM
228. Role of hepatic glucose production and glucose uptake in the pathogenesis of fasting hyperglycemia in type 2 diabetes: Normalization of glucose kinetics by short-term fasting
229. Effect of loss of first-phase secretion on hepatic glucose production and tissue glucose disposal in humans
230. Peripheral tissue glucose uptake is not reduced after an oral glucose load in Southern Italian subjects at risk of developing non-insulin-dependent diabetes mellitus
231. Insulin resistance, but normal basal rate of glucose production in patients with newly diagnosed mild diabetes mellitus
232. Relationship between hepatic glucose production and fasting plasma glucose concentration in patients with non-insulin-dependent diabetes mellitus
233. Glutamine and alanine metabolism in NIDDM
234. Evidence of increased systemic glucose production and gluconeogenesis in early stages of NIDDM
235. Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study
236. Evidence for increased liver glycogen in patients with noninsulin-dependent diabetes mellitus after a 3-day fast
237. Endogenous glucose production, gluconeogenesis and liver glycogen concentration in obese non-diabetic patients
238. Liver glycogen turnover in fed and fasted humans
239. Hepatic glycogen and lactate handling in dietary obese rats
240. Insulin sensitivity accounts for glucose and lactate kinetics after intravenous glucose
241. Plasma lactate concentration in obesity and type 2 diabetes
242. Insulin resistance in obesity is associated with elevated basal lactate levels and diminished lactate appearance following intravenous glucose and insulin
243. Lactate production from glucose and response to insulin in perfused adipocytes from mesentric and epididymal regions of lean and obese rats